The pharmaceutical landscape is undergoing a seismic shift. If you looked at the top-selling drugs twenty years ago, you’d find mostly "small molecule" pills, aspirin, statins, and Ibuprofen. Today, the leaderboard is dominated by biologics. These complex, large-molecule therapies derived from living organisms are treating previously "untreatable" diseases, from chronic autoimmune...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek